female hormones

Product Profile: Norethis 5mg (Norethisterone Tablets) Norethis 5mg contains Norethisterone, a synthetic progestogen with a broad range of gynecological applications. It is frequently used to manage menstrual cycle disorders, endometriosis, and as an effective tool for cycle delay. 1. Clinical Indications & Usage Menstrual Cycle Regulation: Indicated for the treatment of irregular menstrual cycles, heavy menstrual bleeding (menorrhagia), and dysmenorrhea (painful menstruation). Endometriosis: Used to manage symptoms of endometriosis by inducing a state of pseudopregnancy or suppressing the menstrual cycle. Cycle Delay: Often used to postpone menstruation for personal or clinical reasons by delaying the onset of the withdrawal bleed. Premenstrual Syndrome (PMS): Used to alleviate severe symptoms associated with the premenstrual phase. 2. Mechanism of Action Hormonal Suppression: Norethisterone acts on the pituitary gland to inhibit the release of gonadotropins (FSH and LH), thereby preventing ovulation and suppressing ovarian activity. Endometrial Transformation: It exerts a profound effect on the uterine lining, transforming the proliferative endometrium into a secretory state and, with continued use, leading to endometrial atrophy, which reduces heavy bleeding. Progestogenic Effect: By maintaining high systemic levels of progestogen, it effectively prevents the decline in hormone levels that would otherwise trigger menstruation, allowing for the postponement of the menstrual period. 3. Administration and Dosing Regimen: Dosage varies significantly based on the indication (e.g., menorrhagia vs. cycle delay). Dosing must be tailored to the patient's cycle and clinical needs. Consistency: For effective cycle control or delay, it is essential to begin treatment at the specified time in the cycle and follow the regimen strictly without missing doses. Administration: Tablets should be taken orally with water, generally at the same time each day to maintain stable hormone concentrations. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Should not be used in patients with a history of thromboembolic disorders (e.g., DVT, pulmonary embolism), severe liver disease, undiagnosed vaginal bleeding, hormone-sensitive malignancies (such as breast cancer), or during pregnancy. Common Side Effects: Breakthrough bleeding or spotting (common during initial cycles), breast tenderness, nausea, fluid retention, headache, weight changes, and mood fluctuations. Monitoring: Patients with conditions potentially aggravated by fluid retention (e.g., asthma, epilepsy, migraine, or cardiac impairment) should be monitored closely. 📦 Storage, Stability & Commercial Packaging Storage: Store at room temperature (below 30°C / 86°F). Protection: Keep in the original blister packaging to protect from moisture, heat, and light. Security: Keep securely out of reach of children. PRESCRIPTION MEDICINE IS: YES. This profile is compiled strictly for international wholesale procurement and commercial educational research. Norethis is a prescription medicine and must be utilized solely under the direct guidance of a registered medical specialist. All cross-border importing setups must comply with the native health authorities of the destination country 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Product Profile: Pregaloop (Progesterone Injection IP 100mg/ml) Pregaloop injection contains natural Progesterone in an oil-based vehicle, formulated for intramuscular administration. This preparation is used when oral progesterone is not indicated or when higher bioavailability is required for rapid therapeutic response in reproductive medicine and gynecological care. 1. Clinical Indications & Usage Luteal Phase Support: A standard therapy in Assisted Reproductive Technology (ART) protocols (e.g., IVF) to ensure adequate progesterone levels for implantation and maintenance of early pregnancy. Amenorrhea: Treatment of secondary amenorrhea (the absence of menstrual periods) in non-pregnant, non-nursing women. Abnormal Uterine Bleeding: Used in the management of dysfunctional uterine bleeding due to hormonal imbalance. 2. Mechanism of Action Endometrial Transformation: Progesterone acts on an estrogen-primed endometrium, converting it from a proliferative to a secretory state. This is essential for rendering the uterus receptive to embryo implantation and supporting placental development. Hormonal Feedback: It suppresses the production of gonadotropins (FSH and LH) by the pituitary gland and helps normalize the menstrual cycle. Direct Bioavailability: By bypassing the first-pass metabolism in the liver (which occurs with oral dosing), the injectable form provides direct, reliable systemic availability of the hormone. 3. Administration and Dosing Route: Must be administered by deep intramuscular (IM) injection, typically into the upper outer quadrant of the gluteus muscle. Professional Requirement: This is a professional-grade injectable. Administration must be performed by a qualified healthcare provider under aseptic conditions. Preparation: The oil-based solution should be warmed slightly by rolling the vial between the palms if the medication has thickened, and checked for particulate matter prior to injection. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Do not use if the patient has undiagnosed vaginal bleeding, known hypersensitivity to progesterone, severe liver disease, known or suspected breast or genital cancer, or history of thromboembolic disorders (e.g., DVT, pulmonary embolism). Common Side Effects: Injection site reactions (pain, redness, or swelling), breast tenderness, nausea, fatigue, dizziness, and mood changes. Monitoring: Patients should be monitored for signs of fluid retention, which may exacerbate conditions such as asthma, epilepsy, or migraine. 📦 Storage, Stability & Commercial Packaging Storage: Store at controlled room temperature (20°C to 25°C / 68°F to 77°F). Protection: Keep in original packaging to protect from light. Do not refrigerate or freeze. Security: Keep strictly out of reach of children. PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Pregaloop Injection is a prescription medicine and must be utilized solely under the direct guidance of a licensed reproductive endocrinologist or physician. All cross-border importing setups must comply with the native health authorities of the destination country. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Product Profile: Pregaloop 300 (Progesterone Sustained Release 300mg) Pregaloop 300 is a higher-strength, sustained-release formulation of natural Progesterone. It is engineered to provide prolonged hormonal support, ensuring steady plasma concentrations suitable for complex gynecological and reproductive medical protocols. 1. Clinical Indications & Usage Advanced Luteal Phase Support: Utilized in Assisted Reproductive Technology (ART) when higher levels of progesterone are required to ensure robust endometrial receptivity and successful embryo implantation. Complex Hormonal Therapy: Indicated for the treatment of secondary amenorrhea or as part of hormone replacement therapy (HRT) regimens where higher doses are necessary to counteract estrogen effects on the endometrium. Persistent Progesterone Deficiency: Used for patients requiring a higher threshold of luteal supplementation due to clinical history or specific diagnostic requirements. 2. Mechanism of Action Endometrial Maturation: Progesterone transforms the endometrium into a secretory state, facilitating optimal conditions for embryo implantation and subsequent pregnancy maintenance. Hormonal Homeostasis: It suppresses endometrial proliferation and regulates the secretory function of the glandular epithelium. Controlled Pharmacokinetics: The 300mg sustained-release matrix allows for a gradual, consistent delivery of the hormone. This helps to mitigate the rapid fluctuations in serum levels that often occur with immediate-release forms, potentially reducing side effects associated with high-peak concentrations. 3. Administration and Dosing Regimen: The dosage of 300mg is significantly higher than the 200mg variant; it is strictly intended for patients where a higher therapeutic dose has been explicitly determined by a specialist. Administration: The tablet must be swallowed whole with water. Do not crush, chew, or split the tablet, as this will compromise the sustained-release mechanism and could lead to a rapid, unintended dose dump. Consistency: Adherence to the prescribed timing is critical, particularly in fertility cycles, to maintain the necessary hormonal support throughout the required phase of the cycle. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Do not use if the patient has a history of undiagnosed vaginal bleeding, known hypersensitivity, severe liver failure, or current thromboembolic conditions (DVT, pulmonary embolism). Common Side Effects: Drowsiness, sedation, dizziness, bloating, breast discomfort, and headache. Cautionary Note: Given the higher dosage, the sedative effects may be more pronounced. Patients should be cautioned against driving or operating machinery until they understand how the 300mg dose affects their alertness. 📦 Storage, Stability & Commercial Packaging Storage: Store at room temperature (below 30°C / 86°F). Protection: Keep in original blister packaging to protect from moisture and light-induced degradation. Security: Keep securely out of reach of children. PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Pregaloop 300 is a high-dose prescription medicine and must be utilized solely under the direct guidance of a licensed reproductive endocrinologist or gynecologist. All cross-border importing setups must comply with the native health authorities of the destination country. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Product Profile: Pregaloop 200 (Progesterone Sustained Release 200mg) Pregaloop 200 contains micronized Progesterone formulated as a sustained-release tablet. It is a natural progestogen used to supplement or replace progesterone in women whose bodies do not produce sufficient levels. 1. Clinical Indications & Usage Luteal Phase Support: Commonly used in Assisted Reproductive Technology (ART) cycles (e.g., IVF) to support the luteal phase and facilitate embryo implantation. Secondary Amenorrhea: Indicated for the treatment of amenorrhea (absence of menstruation) in women with an intact uterus who have not responded to other hormonal treatments. Prevention of Endometrial Hyperplasia: Often used as a co-treatment in postmenopausal women receiving estrogen therapy to protect the uterine lining. 2. Mechanism of Action Endometrial Preparation: Progesterone transforms the estrogen-primed proliferative endometrium into a secretory endometrium, which is essential for successful embryo implantation and the maintenance of early pregnancy. Hormonal Regulation: It provides negative feedback on the hypothalamus and pituitary to regulate gonadotropin release and maintains the uterine environment. Sustained Release: The special formulation ensures a gradual and consistent release of the hormone into the bloodstream, minimizing the peaks and troughs associated with immediate-release oral formulations. 3. Administration and Dosing Regimen: Dosage is strictly individualized based on the clinical condition, serum hormone levels, and medical history. Administration: Must be taken as directed—usually with water. For sustained-release formulations, the tablet should be swallowed whole and not crushed or chewed to maintain its controlled-release profile. Consistency: Adherence to the specific dosing schedule is vital, particularly in fertility treatments, where timing is critical. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Do not use in patients with undiagnosed vaginal bleeding, known or suspected pregnancy-related tumors, active thrombophlebitis or thromboembolic disorders, severe hepatic dysfunction, or known breast cancer. Common Side Effects: Drowsiness, dizziness, fatigue, breast tenderness, abdominal pain/bloating, and mood fluctuations. Because it can cause somnolence, patients should exercise caution when driving or operating heavy machinery. Monitoring: Patients with a history of cardiovascular disease, epilepsy, migraine, or asthma should be monitored closely, as fluid retention related to progesterone can exacerbate these conditions. 📦 Storage, Stability & Commercial Packaging Storage: Store at controlled room temperature (below 30°C / 86°F). Protection: Keep in original blister packaging to protect from light and moisture. Security: Keep securely out of reach of children. PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Pregaloop 200 is a prescription medicine and must be utilized solely under the direct guidance of a registered medical specialist. All cross-border importing setups must comply with the native health authorities of the destination country. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Product Profile: Shreegoline 0.5mg (Cabergoline) Shreegoline contains Cabergoline, a long-acting dopamine receptor agonist. It is a highly specific and potent pharmaceutical agent primarily used to treat disorders caused by excessive prolactin production (hyperprolactinemia) and in the management of specific neuroendocrine condition 1. Clinical Indications & Usage Hyperprolactinemia: Indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas (prolactinomas). Prolactin-Related Symptoms: Effective in managing symptoms such as galactorrhea (abnormal milk production), amenorrhea, infertility, or hypogonadism associated with high prolactin levels. Parkinson’s Disease: In some clinical settings, it may be used as an adjunct therapy for the treatment of Parkinson’s disease. 2. Mechanism of Action D2 Receptor Agonism: It acts as a potent and selective agonist at dopamine $D_2$ receptors located on the lactotroph cells of the anterior pituitary gland.Prolactin Suppression: By stimulating these receptors, it directly inhibits the secretion of prolactin, the hormone responsible for milk production and the regulation of certain reproductive functions.Long Duration: Due to its high affinity for dopamine receptors and long half-life, it offers prolonged inhibition of prolactin release, allowing for convenient once- or twice-weekly dosing. 3. Administration and Dosing Dosing: The dosage is highly individualized based on serum prolactin levels and patient response. Frequency: Typically administered once or twice weekly. Administration: Tablets should be taken with or without food. Because of its potent dopaminergic effect, therapy is usually initiated at a low dose and titrated upward gradually to minimize gastrointestinal or blood pressure-related side effects. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Do not use if the patient has a history of uncontrolled hypertension, pregnancy-induced hypertension, or known hypersensitivity to ergot derivatives. Cardiac Valve Warning: Prolonged use of dopamine agonists has been associated with valvulopathy. Patients on long-term, high-dose therapy should undergo periodic echocardiographic monitoring. Common Side Effects: Nausea, dizziness, headache, constipation, fatigue, and orthostatic hypotension (sudden drop in blood pressure upon standing). 📦 Storage, Stability & Commercial Packaging Storage: Store at controlled room temperature (20°C to 25°C / 68°F to 77°F). Protection: Keep in the original packaging to protect from light and moisture. Security: Keep securely out of reach of children. PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Shreegoline is a prescription medicine and must be utilized solely under the direct guidance of a licensed endocrinologist or physician. All cross-border importing setups must comply with the native health authorities of the destination country 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Product Profile: Anastrabol (Anastrozole 1mg) Anastrabol contains Anastrozole, a potent non-steroidal aromatase inhibitor. It is a prescription-grade hormonal therapy primarily used to treat hormone receptor-positive breast cancer in postmenopausal women 1. Clinical Indications & Usage Breast Cancer Treatment: Indicated for the adjuvant treatment of early-stage hormone receptor-positive breast cancer in postmenopausal women. It is also used as a first-line treatment for locally advanced or metastatic breast cancer, and for the treatment of advanced disease that has progressed following tamoxifen therapy. Breast Cancer Risk Reduction: May be used in postmenopausal women at high risk of developing breast cancer as a preventative measure. 2. Mechanism of Action Anastrozole works by inhibiting the enzyme aromatase, which is responsible for the peripheral conversion of androgens into estrogen in postmenopausal women. By significantly reducing systemic estrogen levels, the drug effectively “starves“ estrogen-dependent (ER-positive) breast cancer cells, thereby inhibiting their growth and proliferation. 3. Administration and Dosing Regimen: The standard adult dose is 1mg taken orally once daily. Consistency: It should be taken at the same time each day, with or without food. Tablets must be swallowed whole and should not be crushed or chewed. Duration: Treatment is often long-term (spanning several years) and should be continued as directed by a healthcare professional, even if the patient feels well. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Not for use in premenopausal women, pregnant women, or nursing mothers. It should not be used concurrently with tamoxifen or estrogen-containing therapies (like HRT), as these may negate its efficacy. Important Considerations:Bone Health: Because estrogen helps maintain bone density, long-term use can lead to bone thinning (osteoporosis) and an increased risk of fractures. Periodic bone mineral density (BMD) scans are often recommended. Cardiovascular & Cholesterol: May increase total cholesterol levels and has been associated with an increased risk of ischemic heart disease. Patients with a history of heart disease should be monitored closely. Liver Function: While rare, liver function abnormalities can occur; monitoring via blood tests may be necessary 📦 Storage, Stability & Commercial Packaging Storage: Store at controlled room temperature (below 30°C / 86°F). Protection: Keep in original blister packaging to protect from light and moisture. Security: Keep securely out of reach of children and others to prevent unauthorized use. PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Anastrabol is a specialized prescription medication and must be utilized strictly under the supervision of a licensed oncologist or physician. All import and usage must adhere to the laws and medical regulations of the destination country. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383

Product Profile: Bestop (Norethisterone Enanthate & Estradiol Valerate Injection) Bestop is a combined hormonal injectable formulation containing Norethisterone Enanthate (a progestogen) and Estradiol Valerate (an estrogen). This combination is used as a long-acting, reversible contraceptive, providing effective protection against unintended pregnancy through a monthly administration schedule. 1. Clinical Indications & Usage Combined Hormonal Contraception: Indicated for the prevention of pregnancy in women who choose a long-acting injectable method. Cycle Regulation: The combination helps maintain a more stable hormonal profile during the contraceptive period, often resulting in a more predictable withdrawal bleeding pattern compared to progestogen-only injectables. 2. Mechanism of Action The combination utilizes a synergistic hormonal approach: Ovulation Suppression: The estrogen and progestogen components inhibit the secretion of gonadotropins (FSH and LH) from the anterior pituitary gland, preventing the maturation of ovarian follicles and suppressing ovulation. Cervical Mucus Thickening: Progestogen increases the viscosity of cervical secretions, creating a robust barrier that effectively inhibits sperm transport into the upper reproductive tract. Endometrial Inhibition: The combined therapy induces changes in the uterine lining (endometrium), rendering it unreceptive to the implantation of a fertilized ovum. 3. Administration and Dosing Route: Administered by deep intramuscular (IM) injection, typically into the gluteal muscle. Dosing/Schedule: Usually administered as a single monthly injection. Strict adherence to the schedule (every 30 days) is essential to maintain reliable contraceptive efficacy. Professional Requirement: This medication must be administered by a qualified healthcare professional. The injection site should be properly prepared to ensure aseptic conditions. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Should not be used in women with a history of venous thromboembolism (blood clots), arterial thrombosis, severe liver disease, hormone-dependent malignancies (e.g., breast or endometrial cancer), undiagnosed vaginal bleeding, or during pregnancy. Smoking Warning: Smoking cigarettes increases the risk of serious cardiovascular complications (e.g., stroke, myocardial infarction) when using combined hormonal contraceptives, especially in women over age 35. Tobacco use is strongly discouraged. Common Side Effects: Changes in menstrual patterns (including breakthrough bleeding, spotting, or amenorrhea), breast tenderness, nausea, headache, mood swings, weight fluctuations, and injection site reactions. 📦 Storage, Stability & Commercial Packaging Storage: Store at controlled room temperature (below 30°C / 86°F). Protection: Keep in the original packaging to protect from light. Do not freeze. Security: Keep securely out of reach of children. PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Bestop is a prescription medicine and must be utilized solely under the direct guidance of a registered medical specialist. All cross-border importing setups must comply with the native health authorities of the destination country. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383